Evotec SE (EVO) Revenue (2009 - 2025)

Evotec SE (EVO) reported Revenue of $294852.2 for Q4 2025, up 24.74% on a YoY basis from $236373.3 in Q4 2024, and up 53.9% sequentially from $191592.9 in Q3 2025.

Evotec SE (EVO) Revenue (2009 - 2025) Analysis & Trends

Evotec SE (EVO) has 9 years of Revenue data on file, last reported at $294852.2 in Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 24.74% year-over-year to $294852.2; the trailing twelve-month figure through Dec 2025 stood at $925868.3 (down 27.51% YoY), and the FY2025 full-year result was $917.7 million, up 107756581.77% from the prior year.
  • Revenue rose to $294852.2 in Q4 2025, from $191592.9 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $624166.7 in Q4 2023 to a low of $160531.9 in Q1 2021.
  • A 5-year average of $271301.1 and a median of $203049.8 in 2024 frame the typical range for Revenue.
  • Across the five-year window, Revenue climbed 26.56% in 2023 and tumbled 62.13% in 2024, its largest moves.
  • Tracing EVO's Revenue over 5 years: stood at $493009.2 in 2021, then increased by 5.7% to $521100.5 in 2022, then climbed by 19.78% to $624166.7 in 2023, then plunged by 62.13% to $236373.3 in 2024, then grew by 24.74% to $294852.2 in 2025.
  • Business Quant data shows EVO's Revenue at $294852.2 in Q4 2025, $191592.9 in Q3 2025, and $236373.3 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 3.98 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 2.26 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 6.98 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 781.50 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 3.51 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 814.50 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 1.37 Bn
10 Evotec SE 346.06 Mn 345.54 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 294,852.22
Sep 30, 2025 191,592.93
Dec 31, 2024 236,373.30
Sep 30, 2024 203,049.80
Dec 31, 2023 624,166.73
Sep 30, 2023 213,666.36
Jun 30, 2023 232,546.34
Dec 31, 2022 521,100.52
Sep 30, 2022 175,322.77
Jun 30, 2022 183,750.36
Mar 31, 2022 184,817.60
Dec 31, 2021 493,009.15
Sep 30, 2021 188,286.19
Jun 30, 2021 166,450.79
Mar 31, 2021 160,531.93
Dec 31, 2020 429,717.95
Dec 31, 2019 494.11 Mn
Sep 30, 2010 17,912.53
Jun 30, 2010 19,284.47
Mar 31, 2010 13.63 Mn